Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.730
-0.140 (-7.49%)
At close: Sep 10, 2025, 4:00 PM
1.690
-0.040 (-2.31%)
After-hours: Sep 10, 2025, 6:07 PM EDT

Propanc Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2016 - 2020
22010--
Upgrade
Market Cap Growth
27582.21%-25.62%26.73%---
Upgrade
Enterprise Value
25111--
Upgrade
Last Close Price
1.8774.858083.83220059.883095808.383900.00
Upgrade
PB Ratio
1.20-0.11-0.18-0.15--
Upgrade
Debt / Equity Ratio
0.07-0.25-0.17-0.34-0.22-0.45
Upgrade
Quick Ratio
0.010.010.000.000.000.02
Upgrade
Current Ratio
2.240.010.010.010.000.02
Upgrade
Return on Assets (ROA)
-298.55%-1447.01%-1564.19%-2626.42%-2029.40%-2182.06%
Upgrade
Earnings Yield
-231.35%-438.79%-476.99%-603.95%--
Upgrade
FCF Yield
-2.67%-225.39%-198.15%-326.34%--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.